Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (371-380 of 397) with videos related to

Pageof 40
Sort By:
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
JAMA|April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRoberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
NCCN Guidelines Insights: Breast Cancer, Version 1.2017William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Jame Abraham, et al.
The New England Journal of Medicine|June 5, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A Francis, Olivia Pagani, Gini F Fleming, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
NCCN Guidelines Insights: Breast Cancer, Version 3.2018Matthew P Goetz, William J Gradishar, Benjamin O Anderson, et al.
Pageof 40

Showing results (371-380 of 397) with videos related to

Sort By:
Pageof 40
Breast Cancer Research and Treatment|August 17, 2023
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypesLauren Lenz, Chris Neff, Cara Solimeno, et al.
JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
JAMA|April 2, 2024
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast CancerRoberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
NCCN Guidelines Insights: Breast Cancer, Version 1.2017William J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Jame Abraham, et al.
The New England Journal of Medicine|June 5, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerPrudence A Francis, Olivia Pagani, Gini F Fleming, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
NCCN Guidelines Insights: Breast Cancer, Version 3.2018Matthew P Goetz, William J Gradishar, Benjamin O Anderson, et al.
Pageof 40